Columbia Financial, Inc. (NASDAQ:CLBK – Get Free Report) Director Noel R. Holland sold 10,000 shares of the stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $17.06, for a total value of $170,600.00. Following the sale, the director now directly owns 30,501 shares in the company, valued at $520,347.06. This trade represents a 24.69 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
Columbia Financial Trading Down 1.1 %
Shares of NASDAQ CLBK opened at $16.93 on Friday. Columbia Financial, Inc. has a 1-year low of $13.79 and a 1-year high of $20.46. The business has a fifty day moving average price of $17.58 and a 200 day moving average price of $16.68. The stock has a market capitalization of $1.77 billion, a P/E ratio of 112.87 and a beta of 0.19. The company has a debt-to-equity ratio of 1.32, a current ratio of 0.99 and a quick ratio of 0.99.
Columbia Financial (NASDAQ:CLBK – Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Columbia Financial had a net margin of 3.35% and a return on equity of 2.09%. The business had revenue of $124.87 million during the quarter, compared to analyst estimates of $54.95 million. Equities research analysts expect that Columbia Financial, Inc. will post 0.17 EPS for the current fiscal year.
Institutional Investors Weigh In On Columbia Financial
About Columbia Financial
Columbia Financial, Inc, a bank holding company, provides various financial services to businesses and consumers in the United States. Its deposit products include checking, interest-earning checking products and municipal, savings and club deposits, and money market accounts, as well as certificates of deposit.
Featured Articles
- Five stocks we like better than Columbia Financial
- Comparing and Trading High PE Ratio Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The Risks of Owning Bonds
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Columbia Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Financial and related companies with MarketBeat.com's FREE daily email newsletter.